CDGN, S
GTR Test Accession: Help GTR000597442.4
INHERITED DISEASEMETABOLIC DISEASE
Last updated in GTR: 2024-04-25
Last annual review date for the lab: 2023-05-30 LinkOut
At a Glance
Screening
Congenital disorder of glycosylation; Disorder of protein N-glycosylation
A-oligo/Di-oligo Ratio; Apo CIII-0/Apo CIII-2 Ratio; Apo CIII-1/Apo CIII-2 Ratio; Mono-oligo/Di-oligo Ratio; N-glycosylated proteins; ...
Biochemical Genetics - Analyte: MALDI-TOF/TOF
Screening for N-linked congenital disorders of glycosylation
Not provided
Establish or confirm diagnosis
Ordering Information
Offered by: Help
Test short name: Help
CDGN
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Dentist
  • Licensed Physician
  • Nurse Practitioner
  • Physician Assistant
  • Public Health Mandate
  • Registered Nurse
Lab contact: Help
Gisele (Gessi) Bentz Pino, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
biochemicalgenetics@mayo.edu
1-800-533-1710
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
https://www.mayocliniclabs.com/test-catalog/Specimen/65485
Order URL
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Based on applicable state law
Test strategy: Help
https://www.mayocliniclabs.com/en/articles/resources/-/media/it-mmfiles/special%20instructions/8/3/3/congenital-disorders-of-glycosylation-algorithm.pdf
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Conditions Help
Total conditions: 2
Condition/Phenotype Identifier
Test Targets
Analytes Help
Total analytes: 6
Analyte Associated Condition
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Analyte
MALDI-TOF/TOF
* Instrument: Not provided
Clinical Information
Test purpose: Help
Screening
Clinical utility: Help
Establish or confirm diagnosis
View citations (1)
  • Congenital disorders of glycosylation. Chang IJ, et al. Ann Transl Med. 2018;6(24):477. doi:10.21037/atm.2018.10.45. PMID: 30740408.

Target population: Help
Screening for N-linked congenital disorders of glycosylation
View citations (1)
  • Congenital disorders of glycosylation. Chang IJ, et al. Ann Transl Med. 2018;6(24):477. doi:10.21037/atm.2018.10.45. PMID: 30740408.
Research:
Is research allowed on the sample after clinical testing is complete? Help
N/A
Recommended fields not provided:
Technical Information
Test Procedure: Help
N-linked oligosaccharides are enzymatically released, purified, and then detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).(Unpublished Mayo method)
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Accuracy was assessed by method comparison and was acceptable. Intra assay precision was performed with 3 different samples, there was 100% concordance between replicates (N=3 each). Inter assay precision was performed with 3 different samples, there was 100% concordance between replicates (N=3 each).
Assay limitations: Help
No significant cautionary statements
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
European Research Network for the Evaluation and Improvement of Screening Diagnosis and Treatment of Inherited Metabolic Disorders - External Quality Assessment Schemes, ERNDIM EQAS

Description of PT method: Help
Formal PT program

Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.